SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-22-000393
Filing Date
2022-02-17
Accepted
2022-02-17 16:00:46
Documents
1
Period of Report
2022-02-15

Document Format Files

Seq Description Document Type Size
1 kintara_fm4feb152022.html 4  
1 kintara_fm4feb152022.xml 4 3716
  Complete submission text file 0000905718-22-000393.txt   5372
Mailing Address ARENA PHARMACEUTICALS INC 6166 NANCY RIDER DRIVE SAN DIEGO CA 92121
Business Address
Hoffman Robert E. (Reporting) CIK: 0001166288 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 22647982

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations